{"id":18843,"date":"2022-03-09T08:24:02","date_gmt":"2022-03-09T16:24:02","guid":{"rendered":"https:\/\/marketdepth.com\/?p=18843"},"modified":"2022-03-09T08:24:03","modified_gmt":"2022-03-09T16:24:03","slug":"kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare","status":"publish","type":"post","link":"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/","title":{"rendered":"Kala Pharmaceuticals Reports EYSUVIS Coverage on UnitedHealthcare Commercial and Cigna Medicare"},"content":{"rendered":"\n<p>Kala Pharmaceuticals, Inc. (NASDAQ: KALA) has <a href=\"https:\/\/finance.yahoo.com\/news\/kala-pharmaceuticals-announces-eysuvis-now-130000614.html\">reported<\/a> that UnitedHealthcare has added EYSUVIS as a covered brand on its commercial formularies effective March 2022.\u00a0 EYSUVIS has covered 118 million lives or 70% of all commercial lives.\u00a0 \u201cToday\u2019s announcement marks significant progress toward our goal of expanding access to EYSUVIS for the millions of people who suffer from dry eye disease, including dry eye flares,\u201d said Todd Bazemore, President and Chief Operating Officer of Kala Pharmaceuticals. \u201cWe look forward to continuing to engage with other commercial and Medicare Part D health plans as we execute on our goal of providing broad market access to EYSUVIS for eye care professionals and their patients.\u201d<\/p>\n\n\n\n<h5 class=\"wp-block-heading\">Preferred Brand<\/h5>\n\n\n\n<p>Kala reported that Cigna Medicare has added EYSUVIS as a preferred brand effective on February 2022, adding an additional 1.9 million Medicare lives.<\/p>\n\n\n\n<h5 class=\"wp-block-heading\">Commercially Available<\/h5>\n\n\n\n<p>EYSUVIS has become commercially available since January 2021 as the first and only FDA-approved medicine for short-term treatment of the signs and symptoms of dry eye disease.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"Kala Pharmaceuticals, Inc. (NASDAQ: KALA) has reported that UnitedHealthcare has added EYSUVIS as a covered brand on its commercial formularies effective March 2022.\u00a0 EYSUVIS has covered 118 million lives or 70% of all commercial lives.\u00a0 \u201cToday\u2019s announcement marks significant progress toward our goal of expanding access to EYSUVIS for the millions of people who suffer&#8230; <a class=\"view-article\" href=\"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/\">View Article<\/a>","protected":false},"author":3,"featured_media":17769,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":0,"footnotes":""},"categories":[31,17,8,11,16],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Kala Pharmaceuticals Reports EYSUVIS Coverage on UnitedHealthcare Commercial and Cigna Medicare - MarketDepth<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kala Pharmaceuticals Reports EYSUVIS Coverage on UnitedHealthcare Commercial and Cigna Medicare - MarketDepth\" \/>\n<meta property=\"og:description\" content=\"Kala Pharmaceuticals, Inc. (NASDAQ: KALA) has reported that UnitedHealthcare has added EYSUVIS as a covered brand on its commercial formularies effective March 2022.\u00a0 EYSUVIS has covered 118 million lives or 70% of all commercial lives.\u00a0 \u201cToday\u2019s announcement marks significant progress toward our goal of expanding access to EYSUVIS for the millions of people who suffer... View Article\" \/>\n<meta property=\"og:url\" content=\"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/\" \/>\n<meta property=\"og:site_name\" content=\"MarketDepth\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/marketdepthnews\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-09T16:24:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-09T16:24:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/10\/CancerResearch.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1347\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"MarketDepth\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MarketDepthNews\" \/>\n<meta name=\"twitter:site\" content=\"@MarketDepthNews\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"MarketDepth\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/\"},\"author\":{\"name\":\"MarketDepth\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69\"},\"headline\":\"Kala Pharmaceuticals Reports EYSUVIS Coverage on UnitedHealthcare Commercial and Cigna Medicare\",\"datePublished\":\"2022-03-09T16:24:02+00:00\",\"dateModified\":\"2022-03-09T16:24:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/\"},\"wordCount\":170,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/marketdepth.com\/#organization\"},\"articleSection\":[\"Business\",\"Headlines\",\"Healthcare\",\"Investing\",\"What's Hot\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/\",\"url\":\"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/\",\"name\":\"Kala Pharmaceuticals Reports EYSUVIS Coverage on UnitedHealthcare Commercial and Cigna Medicare - MarketDepth\",\"isPartOf\":{\"@id\":\"https:\/\/marketdepth.com\/#website\"},\"datePublished\":\"2022-03-09T16:24:02+00:00\",\"dateModified\":\"2022-03-09T16:24:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/marketdepth.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kala Pharmaceuticals Reports EYSUVIS Coverage on UnitedHealthcare Commercial and Cigna Medicare\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/marketdepth.com\/#website\",\"url\":\"https:\/\/marketdepth.com\/\",\"name\":\"MarketDepth\",\"description\":\"Stock Market News &amp; Headlines\",\"publisher\":{\"@id\":\"https:\/\/marketdepth.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/marketdepth.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/marketdepth.com\/#organization\",\"name\":\"MarketDepth\",\"url\":\"https:\/\/marketdepth.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg\",\"contentUrl\":\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg\",\"width\":1500,\"height\":1000,\"caption\":\"MarketDepth\"},\"image\":{\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/marketdepthnews\",\"https:\/\/twitter.com\/MarketDepthNews\",\"https:\/\/www.instagram.com\/marketdepth\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69\",\"name\":\"MarketDepth\",\"url\":\"https:\/\/marketdepth.com\/author\/3\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kala Pharmaceuticals Reports EYSUVIS Coverage on UnitedHealthcare Commercial and Cigna Medicare - MarketDepth","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/","og_locale":"en_US","og_type":"article","og_title":"Kala Pharmaceuticals Reports EYSUVIS Coverage on UnitedHealthcare Commercial and Cigna Medicare - MarketDepth","og_description":"Kala Pharmaceuticals, Inc. (NASDAQ: KALA) has reported that UnitedHealthcare has added EYSUVIS as a covered brand on its commercial formularies effective March 2022.\u00a0 EYSUVIS has covered 118 million lives or 70% of all commercial lives.\u00a0 \u201cToday\u2019s announcement marks significant progress toward our goal of expanding access to EYSUVIS for the millions of people who suffer... View Article","og_url":"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/","og_site_name":"MarketDepth","article_publisher":"https:\/\/www.facebook.com\/marketdepthnews","article_published_time":"2022-03-09T16:24:02+00:00","article_modified_time":"2022-03-09T16:24:03+00:00","og_image":[{"width":1920,"height":1347,"url":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/10\/CancerResearch.jpg","type":"image\/jpeg"}],"author":"MarketDepth","twitter_card":"summary_large_image","twitter_creator":"@MarketDepthNews","twitter_site":"@MarketDepthNews","twitter_misc":{"Written by":"MarketDepth","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/#article","isPartOf":{"@id":"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/"},"author":{"name":"MarketDepth","@id":"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69"},"headline":"Kala Pharmaceuticals Reports EYSUVIS Coverage on UnitedHealthcare Commercial and Cigna Medicare","datePublished":"2022-03-09T16:24:02+00:00","dateModified":"2022-03-09T16:24:03+00:00","mainEntityOfPage":{"@id":"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/"},"wordCount":170,"commentCount":0,"publisher":{"@id":"https:\/\/marketdepth.com\/#organization"},"articleSection":["Business","Headlines","Healthcare","Investing","What's Hot"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/","url":"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/","name":"Kala Pharmaceuticals Reports EYSUVIS Coverage on UnitedHealthcare Commercial and Cigna Medicare - MarketDepth","isPartOf":{"@id":"https:\/\/marketdepth.com\/#website"},"datePublished":"2022-03-09T16:24:02+00:00","dateModified":"2022-03-09T16:24:03+00:00","breadcrumb":{"@id":"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/marketdepth.com\/kala-pharmaceuticals-reports-eysuvis-coverage-on-unitedhealthcare-commercial-and-cigna-medicare\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/marketdepth.com\/"},{"@type":"ListItem","position":2,"name":"Kala Pharmaceuticals Reports EYSUVIS Coverage on UnitedHealthcare Commercial and Cigna Medicare"}]},{"@type":"WebSite","@id":"https:\/\/marketdepth.com\/#website","url":"https:\/\/marketdepth.com\/","name":"MarketDepth","description":"Stock Market News &amp; Headlines","publisher":{"@id":"https:\/\/marketdepth.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/marketdepth.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/marketdepth.com\/#organization","name":"MarketDepth","url":"https:\/\/marketdepth.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/","url":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg","contentUrl":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg","width":1500,"height":1000,"caption":"MarketDepth"},"image":{"@id":"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/marketdepthnews","https:\/\/twitter.com\/MarketDepthNews","https:\/\/www.instagram.com\/marketdepth\/"]},{"@type":"Person","@id":"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69","name":"MarketDepth","url":"https:\/\/marketdepth.com\/author\/3\/"}]}},"_links":{"self":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/18843"}],"collection":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/comments?post=18843"}],"version-history":[{"count":1,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/18843\/revisions"}],"predecessor-version":[{"id":18844,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/18843\/revisions\/18844"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/media\/17769"}],"wp:attachment":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/media?parent=18843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/categories?post=18843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/tags?post=18843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}